AI-generated summary
In a randomized trial of 50 patients with Behcet's disease-associated oral ulcers, the authors compared a 980 nm diode laser with topical 0.1% triamcinolone acetonide. The authors report that the laser group had better composite ulcer activity and pain scores on early days and fewer ulcers on days three and five, with no adverse effects reported in either group.
- Participants
- 50
- Who or what was studied
- Patients with Behcet's disease-associated oral ulcers
- Wavelengths
- 980 nm
- Limits stated in the abstract
- The abstract does not describe the sample size per group or the duration of follow-up, and it reports significance on only some of the measured outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 980 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Visual analogue scale, Statistical significance, Trial registration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.